Innovations in the Integrated Management of Breast Cancer
Breast cancer is acknowledged as an international priority in healthcare. It is currently the most common cancer in women worldwide, with demographic trends indicating a continuous increase in incidence. Over the years, increasing efforts and resources have been devoted to the search for a systemati...
Guardado en:
| Formato: | Online |
|---|---|
| Lenguaje: | inglés |
| Publicado: |
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| Materias: | |
| Acceso en línea: | ONIX_20220506_9783036538020_33 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1869520693187575808 |
|---|---|
| collection | Directory of Open Access Books |
| description | Breast cancer is acknowledged as an international priority in healthcare. It is currently the most common cancer in women worldwide, with demographic trends indicating a continuous increase in incidence. Over the years, increasing efforts and resources have been devoted to the search for a systematic and optimized strategy in breast cancer diagnosis and treatment. Today, the Breast Unit model is considered the gold standard in order to ensure optimal patient-centered and research-based clinical services through multidisciplinary and integrated management.Surgical treatment has gradually evolved toward less aggressive approaches with the adoption of new therapeutic strategies. The evolution of evidence-based guidelines in such leading disciplines as radiation and medical oncology has led to a steady improvement in survival rates. This Special Issue will highlight innovations in the integrated management of breast cancer, their potential advantages, and the many open issues that still need to be properly defined and addressed. |
| format | Online |
| id | doab-20.500.12854ir-80967 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2022 |
| publishDateRange | 2022 |
| publishDateSort | 2022 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-809672024-03-31T13:08:10Z Innovations in the Integrated Management of Breast Cancer Franceschini, Gianluca Sanchez, Alejandro Martin Masetti, Riccardo metastatic breast cancer breast surgery immune system metabolic derangements precision medicine integrated therapies advanced breast cancer mTOR inhibitor CDK4/6 inhibitor endocrine resistance breast cancer pregnancy chemotherapy tailoring personalization DataMart real world data predictive model healthcare breast-conserving surgery non-palpable breast lesions image-guided localization preoperative breast localization breast ultrasound large database standardized data collection networks nipple-sparing mastectomy immediate breast reconstruction acellular dermal matrix (ADM) aesthetic and oncological outcomes quality of life rare breast cancer osteoclast-like giant cells gene profiling Oncotype Dx adjuvant treatment neoadjuvant chemotherapy sentinel lymph node systemic treatment locally advanced breast cancer mini-invasive treatment liver metastases hepatic surgery personalized medicine sarcopenia physical performance frailty older cancer patients clinical trial patient enrollment artificial intelligence machine learning lung cancer oncology web app conventional CT and CT angiography DIEP flap planning multidisciplinary treatment evidence-based medicine personalized treatment oncological outcomes patient quality of life normal breast breast pathology hormone receptor hormone expression lymphedema lymphaticovenous anastomosis vascularized lymph node transfer lymphatic microsurgery radiotherapy oligometastatic breast cancer locoregional therapy CDK4/6 inhibitors multidisciplinary AMH ovarian reserve pregnancy desire subtypes breast cancer miRNAs breast cancer treatment next-generation-sequencing target therapy old age survival vitamin D ductal breast cancer in situ breast cancer lobular breast cancer histology n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology Breast cancer is acknowledged as an international priority in healthcare. It is currently the most common cancer in women worldwide, with demographic trends indicating a continuous increase in incidence. Over the years, increasing efforts and resources have been devoted to the search for a systematic and optimized strategy in breast cancer diagnosis and treatment. Today, the Breast Unit model is considered the gold standard in order to ensure optimal patient-centered and research-based clinical services through multidisciplinary and integrated management.Surgical treatment has gradually evolved toward less aggressive approaches with the adoption of new therapeutic strategies. The evolution of evidence-based guidelines in such leading disciplines as radiation and medical oncology has led to a steady improvement in survival rates. This Special Issue will highlight innovations in the integrated management of breast cancer, their potential advantages, and the many open issues that still need to be properly defined and addressed. 2022-05-06T11:18:44Z 2022-05-06T11:18:44Z 2022 book ONIX_20220506_9783036538020_33 9783036538020 9783036538013 https://directory.doabooks.org/handle/20.500.12854/80967 eng image/jpeg Attribution 4.0 International https://mdpi.com/books/pdfview/book/5307 https://mdpi.com/books/pdfview/book/5307 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-3801-3 10.3390/books978-3-0365-3801-3 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036538020 9783036538013 278 Basel open access |
| spellingShingle | metastatic breast cancer breast surgery immune system metabolic derangements precision medicine integrated therapies advanced breast cancer mTOR inhibitor CDK4/6 inhibitor endocrine resistance breast cancer pregnancy chemotherapy tailoring personalization DataMart real world data predictive model healthcare breast-conserving surgery non-palpable breast lesions image-guided localization preoperative breast localization breast ultrasound large database standardized data collection networks nipple-sparing mastectomy immediate breast reconstruction acellular dermal matrix (ADM) aesthetic and oncological outcomes quality of life rare breast cancer osteoclast-like giant cells gene profiling Oncotype Dx adjuvant treatment neoadjuvant chemotherapy sentinel lymph node systemic treatment locally advanced breast cancer mini-invasive treatment liver metastases hepatic surgery personalized medicine sarcopenia physical performance frailty older cancer patients clinical trial patient enrollment artificial intelligence machine learning lung cancer oncology web app conventional CT and CT angiography DIEP flap planning multidisciplinary treatment evidence-based medicine personalized treatment oncological outcomes patient quality of life normal breast breast pathology hormone receptor hormone expression lymphedema lymphaticovenous anastomosis vascularized lymph node transfer lymphatic microsurgery radiotherapy oligometastatic breast cancer locoregional therapy CDK4/6 inhibitors multidisciplinary AMH ovarian reserve pregnancy desire subtypes breast cancer miRNAs breast cancer treatment next-generation-sequencing target therapy old age survival vitamin D ductal breast cancer in situ breast cancer lobular breast cancer histology n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology Innovations in the Integrated Management of Breast Cancer |
| title | Innovations in the Integrated Management of Breast Cancer |
| title_full | Innovations in the Integrated Management of Breast Cancer |
| title_fullStr | Innovations in the Integrated Management of Breast Cancer |
| title_full_unstemmed | Innovations in the Integrated Management of Breast Cancer |
| title_short | Innovations in the Integrated Management of Breast Cancer |
| title_sort | innovations in the integrated management of breast cancer |
| topic | metastatic breast cancer breast surgery immune system metabolic derangements precision medicine integrated therapies advanced breast cancer mTOR inhibitor CDK4/6 inhibitor endocrine resistance breast cancer pregnancy chemotherapy tailoring personalization DataMart real world data predictive model healthcare breast-conserving surgery non-palpable breast lesions image-guided localization preoperative breast localization breast ultrasound large database standardized data collection networks nipple-sparing mastectomy immediate breast reconstruction acellular dermal matrix (ADM) aesthetic and oncological outcomes quality of life rare breast cancer osteoclast-like giant cells gene profiling Oncotype Dx adjuvant treatment neoadjuvant chemotherapy sentinel lymph node systemic treatment locally advanced breast cancer mini-invasive treatment liver metastases hepatic surgery personalized medicine sarcopenia physical performance frailty older cancer patients clinical trial patient enrollment artificial intelligence machine learning lung cancer oncology web app conventional CT and CT angiography DIEP flap planning multidisciplinary treatment evidence-based medicine personalized treatment oncological outcomes patient quality of life normal breast breast pathology hormone receptor hormone expression lymphedema lymphaticovenous anastomosis vascularized lymph node transfer lymphatic microsurgery radiotherapy oligometastatic breast cancer locoregional therapy CDK4/6 inhibitors multidisciplinary AMH ovarian reserve pregnancy desire subtypes breast cancer miRNAs breast cancer treatment next-generation-sequencing target therapy old age survival vitamin D ductal breast cancer in situ breast cancer lobular breast cancer histology n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology |
| topic_facet | metastatic breast cancer breast surgery immune system metabolic derangements precision medicine integrated therapies advanced breast cancer mTOR inhibitor CDK4/6 inhibitor endocrine resistance breast cancer pregnancy chemotherapy tailoring personalization DataMart real world data predictive model healthcare breast-conserving surgery non-palpable breast lesions image-guided localization preoperative breast localization breast ultrasound large database standardized data collection networks nipple-sparing mastectomy immediate breast reconstruction acellular dermal matrix (ADM) aesthetic and oncological outcomes quality of life rare breast cancer osteoclast-like giant cells gene profiling Oncotype Dx adjuvant treatment neoadjuvant chemotherapy sentinel lymph node systemic treatment locally advanced breast cancer mini-invasive treatment liver metastases hepatic surgery personalized medicine sarcopenia physical performance frailty older cancer patients clinical trial patient enrollment artificial intelligence machine learning lung cancer oncology web app conventional CT and CT angiography DIEP flap planning multidisciplinary treatment evidence-based medicine personalized treatment oncological outcomes patient quality of life normal breast breast pathology hormone receptor hormone expression lymphedema lymphaticovenous anastomosis vascularized lymph node transfer lymphatic microsurgery radiotherapy oligometastatic breast cancer locoregional therapy CDK4/6 inhibitors multidisciplinary AMH ovarian reserve pregnancy desire subtypes breast cancer miRNAs breast cancer treatment next-generation-sequencing target therapy old age survival vitamin D ductal breast cancer in situ breast cancer lobular breast cancer histology n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology |
| url | ONIX_20220506_9783036538020_33 |